SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,933.59 -539.35
( -0.70%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,058.92 -203.24
(-0.31%)

Nikkei 225

10,888.36 2.20
(0.02%)

Forex

USD-INR

95.31 -0.39
(-0.41%)

EUR-INR

111.19 -0.48
(-0.43%)

GBP-INR

129.97 -0.53
(-0.40%)

JPY-INR

0.60 0.00
(-0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4616629

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

46.61

14997.45

EPS(TTM)

Face Value()

Div & Yield %

7.1

0.27

Back

rane holdings ltd

Mastek consolidated net profit rises 15.02% in the June 2026 quarter

Jul 22,2026

Net profit of Mastek rose 15.02% to Rs 105.88 crore in the quarter ended June 2026 as against Rs 92.05 crore during the previous quarter ended June 2025. Sales rose 7.71% to Rs 985.25 crore in the quarter ended June 2026 as against Rs 914.70 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	985.25	914.70	8
OPM %	15.36	15.01	-
PBDT	156.80	139.12	13
PBT	138.46	120.70	15
NP	105.88	92.05	15

76,933.59 -539.35 ( -0.70%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,058.92 -203.24 (-0.31%)

10,888.36 2.20 (0.02%)

95.31 -0.39 (-0.41%)

111.19 -0.48 (-0.43%)

129.97 -0.53 (-0.40%)

0.60 0.00 (-0.54%)